OMEPRAZOLE SUBSTIPHARM 20 mg, gélule gastro-résistante — flacon(s) polyéthylène haute densité (PEHD) de 14 gélule(s) muni d'une capsule polypropylène

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400936482913
  • CIP7 3648291
  • CIS 66060546

What the source publishes

Holder
SUBSTIPHARM
Active ingredients
OMÉPRAZOLE
Form
gélule gastro-résistant(e)
Package
flacon(s) polyéthylène haute densité (PEHD) de 14 gélule(s) muni d'une capsule polypropylène
Routes
orale
Administrative status
cancelled
Supply regime
liste II
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2004-07-20
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400936482913
{
  "cis": "66060546",
  "cip7": "3648291",
  "form": "gélule gastro-résistant(e)",
  "name": "OMEPRAZOLE SUBSTIPHARM 20 mg, gélule gastro-résistante — flacon(s) polyéthylène haute densité (PEHD) de 14 gélule(s) muni d'une capsule polypropylène",
  "cip13": "3400936482913",
  "holder": "SUBSTIPHARM",
  "routes": [
    "orale"
  ],
  "holders": [
    "SUBSTIPHARM"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "2.99",
  "authorisedOn": "2004-07-20",
  "compositions": [
    {
      "name": "OMÉPRAZOLE",
      "nature": "SA",
      "strength": "20 mg",
      "linkageNumber": "1",
      "substanceCode": "04773",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste II",
  "dispensingFee": "1.02",
  "medicinePrice": "1.97",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "OMEPRAZOLE SUBSTIPHARM 20 mg, gélule gastro-résistante",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "flacon(s) polyéthylène haute densité (PEHD) de 14 gélule(s) muni d'une capsule polypropylène",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2023-02-28",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "cancelled",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "OMÉPRAZOLE"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste II"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation abrogée",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400936482913"